Estee Lauder Companies Inc (EL) Stock News

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Dun & Bradstreet Holdings, alleging false and misleading statements regarding a merger with Clearlake Capital Group, including omissions about executive interests and financial advisor conflicts. Additional cases involve Duolingo, Inc. and XTI Aerospace, Inc. The lead plaintiff deadline for the DNB case is November 10, 2026.

Rosen Law Firm is urging Duolingo investors who purchased stock between May 2, 2025 and February 26, 2026 to join a securities class action lawsuit. The lawsuit alleges that Duolingo made false statements about user growth by concealing that increased monetization efforts, ad volume, and lower-quality AI-generated content were negatively impacting daily active users and product quality. The lead plaintiff deadline is December 7, 2026.

Rosen Law Firm has filed a securities class action lawsuit against Celsius Holdings, Inc. (CELH) on behalf of investors who purchased securities between February 21, 2025 and June 3, 2026. The lawsuit alleges that Celsius made materially false and misleading statements regarding the cardiac risks of its Alani Nu products and inappropriately marketed these products to consumers under 18 years old. The lead plaintiff deadline is November 3, 2026.

A securities class action lawsuit has been filed against Better Home & Finance Holding Company (BETR) for allegedly making false and misleading statements about its conversion funnel and $1 billion monthly funded volume target. Investors who purchased BETR securities between March 13, 2026 and May 7, 2026 are encouraged to join the class action before the November 20, 2026 lead plaintiff deadline.

Rosen Law Firm is urging FuelCell Energy (FCEL) investors who purchased securities between June 24, 2026 and September 1, 2026 to join a class action lawsuit. The lawsuit alleges that FuelCell made false statements about its business, concealing inadequate manufacturing capacity, slower production rates, higher costs, and likely CEPA-related charges that materially misled investors. The lead plaintiff deadline is November 10, 2026.

FREELANDER will showcase its FREELANDER 8 model at the 2026 Chery International User Summit in Wuhan, China. The vehicle features British design heritage, advanced L2+ driver assistance systems, a hybrid powertrain with dual electric motors, and an 8K Mini LED display. The summit, themed 'Green Technology for Our Future Life,' will include international test drives and demonstrations of the vehicle's capabilities across various terrains.

Rosen Law Firm has filed a class action lawsuit against Triller Group Inc. (NASDAQ: ILLR) on behalf of investors who purchased securities between October 16, 2024 and December 29, 2025. The lawsuit alleges that Triller made materially false and misleading statements regarding its control of BKFC, financial reporting compliance, NASDAQ listing requirements, and disclosure controls. Investors who wish to serve as lead plaintiff must file by December 14, 2026.

Rosen Law Firm has filed securities class action lawsuits against Millrose Properties, Hims & Hers Health, and Doximity for alleged disclosure failures and misleading statements to investors. Millrose Properties is accused of misrepresenting its business objectives and leasing properties at a loss. Investors have until December 8, 2026 to move the court to serve as lead plaintiff.

David Solomon, CEO of Goldman Sachs, has been named the new chair of The Business Council, succeeding Brian Cornell of Target Corporation. Solomon will lead the organization during a pivotal period marked by AI advancement and complex global economic challenges. The Business Council, established in 1933, serves as a forum for world-leading CEOs to collaborate on business solutions.

Rosen Law Firm has filed a securities class action lawsuit against Netcapital Inc. on behalf of investors who purchased securities between December 15, 2021 and September 3, 2026. The lawsuit alleges that Netcapital made false statements and failed to disclose improper revenue recognition from sham consulting agreements, backdated and forged contracts, undisclosed related-party transactions, and false Sarbanes-Oxley certifications. Investors must move the court by December 7, 2026 to serve as lead plaintiff.

Rosen Law Firm is urging investors who purchased Lincoln Educational Services Corporation (LINC) securities between May 11, 2026 and August 9, 2026 to join a class action lawsuit before the November 10, 2026 deadline. The lawsuit alleges that defendants made false statements about the company's admissions process and student conversion rates, claiming the company experienced a significant drop in student starts relative to enrollment, making positive statements about the business materially misleading.

Rosen Law Firm is notifying Beta Bionics, Inc. investors of a November 3, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made false statements about its iLet Bionic Pancreas insulin pump, which the FDA found to be malfunctioning and causing dangerously high insulin dosing. The company allegedly failed to implement meaningful corrective actions despite thousands of complaints and hundreds of life-threatening events.

Vallourec, a world leader in premium seamless tubular solutions, will showcase its VAM® portfolio and expanded CLEANWELL® dope-free solution at ADIPEC 2026 in Abu Dhabi (November 2-5, 2026). The company will present VAM® 21, VAM® HTTC connections, VAM® SPRINT-TC for unconventional applications, and Delphy, its hydrogen storage solution, alongside Vallourec® Services offerings.

Vallourec, a global leader in premium tubular solutions, will showcase its VAM® connections and expanded CLEANWELL® grease-free solution at ADIPEC 2026 in Abu Dhabi (November 2-5, 2026). The company will present advanced offerings including VAM® 21, VAM® HTTC, VAM® SPRINT-TC for unconventional applications, and Delphy, its hydrogen underground storage solution, alongside engineering and operational services.

The Rosen Law Firm has issued notices regarding class action securities lawsuits against three companies: Celsius Holdings (CELH) for allegedly failing to disclose health risks associated with its energy drink products and marketing to minors; Taboola.com (TBLA) with an October 20 deadline; and XTI Aerospace (XTIA) with an October 27 deadline. Investors who suffered losses exceeding $100,000 are urged to seek legal counsel.

Rosen Law Firm has filed a class action lawsuit against Duolingo, Inc. on behalf of investors who purchased Class A common stock between May 2, 2025 and February 26, 2026. The lawsuit alleges that Duolingo made materially false statements regarding Daily Active User growth, failed to disclose that increased user friction from ads and subscription upsells was negatively impacting DAU growth, and that low-quality AI-generated content was degrading the product experience and user retention. The lead plaintiff deadline is December 7, 2026.

Rosen Law Firm is notifying investors of Qfin Holdings who purchased securities between March 18, 2026 and August 25, 2026 of an important November 30, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Qfin defendants made false and misleading statements regarding the resiliency of the company's business and downplayed the negative impact of regulatory headwinds on financial results.

Rosen Law Firm has filed securities class action lawsuits against FuelCell Energy, Hyliion Holdings, and Tigo Energy, alleging that defendants made false and misleading statements regarding their business operations and financial prospects. Investors who purchased securities during specified class periods are encouraged to secure counsel before upcoming deadlines, with the FuelCell case having a November 10, 2026 lead plaintiff deadline.

Robbins LLP is reminding investors about a class action lawsuit against Celsius Holdings (CELH) for allegedly misleading investors about the safety of Alani Nu energy drinks marketed to teenagers. The lawsuit covers the period from February 21, 2025 to June 3, 2026. The case was triggered by reports of a 17-year-old's death linked to the high-caffeine drinks and a subsequent investigation by the Texas Attorney General. The stock fell significantly following these revelations.

Rosen Law Firm has filed a securities class action lawsuit against The Ensign Group, Inc. on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, fraudulent Medicaid/Medicare billing, falsification of nursing assistant hours, and illegal licensing schemes. Investors who wish to serve as lead plaintiff must file by December 7, 2026.

Rosen Law Firm announces a securities class action lawsuit against DICK'S Sporting Goods, alleging the company made materially false and misleading statements regarding its Foot Locker acquisition cleanup efforts and exposure to excess inventory and promotional pressures in the athletic footwear industry. Investors who purchased DKS stock between September 8, 2025 and August 24, 2026 may be eligible for compensation. The lead plaintiff deadline is November 3, 2026.

A securities class action has been filed against FuelCell Energy (FCEL) for allegedly making materially false and misleading statements about manufacturing capacity and production economics related to a major Fit Energy agreement. The company failed to disclose that actual manufacturing capacity was inadequate to meet contractual obligations, resulting in severe gross losses. Following the disclosure of a $45.3 million net loss and $17 million in Phase 0 charges on September 2, 2026, FCEL stock plummeted 16%. Investors who purchased shares between June 24 and September 1, 2026, may be eligible to participate as lead plaintiffs by November 10, 2026.

Celsius Holdings (CELH) is trending but faces headwinds. The stock has underperformed the S&P 500 over the past month (+1.1% vs +2.1%). While revenue growth is solid at +26.6% for the current fiscal year, earnings estimates have declined over the past month, and the company received a Zacks Rank #4 (Sell) rating. The stock trades at a premium valuation (Grade D) and is expected to underperform the broader market in the near term.

Entrada Therapeutics announced positive topline data from Cohort 1 of the Phase 1/2 ELEVATE-45-201 study of ENTR-601-45 for DMD patients amenable to exon 45 skipping. The trial met primary safety and tolerability objectives at the 5 mg/kg dose with favorable safety profile and demonstrated a 0.10% mean increase in dystrophin production. The company expects significant increases in dystrophin production at higher doses in future cohorts and plans to report Cohort 2 data (10 mg/kg) in the first half of 2027.

Entrada Therapeutics announced that an independent Data Monitoring Committee has recommended advancing to Cohort 3 at the top dose of 18 mg/kg in the ELEVATE-44-201 Phase 1/2 clinical study of ENTR-601-44 for Duchenne muscular dystrophy. The dose escalation marks progress in understanding the drug's safety and efficacy profile. Cohort 1 data is expected by year-end 2026, with Cohort 2 data anticipated in Q1 2027.

Rosen Law Firm has filed securities class action lawsuits against multiple companies. The primary case involves Hims & Hers Health, Inc., alleging the company made false statements about data privacy, charged consumers for prescriptions without proper consultation, and failed to disclose regulatory scrutiny. The firm is seeking lead plaintiffs with a November 2, 2026 deadline. Similar lawsuits have been filed against Papa John's International and Millrose Properties.

Rosen Law Firm announces securities class action lawsuits against Papa John's International (PZZA) and other companies. The Papa John's lawsuit alleges the company made materially false statements about its transformation efforts, concealing that the process was taking longer than expected and failing to prevent market share losses. Investors who purchased stock during the class period may be eligible for compensation. The lead plaintiff deadline is November 2, 2026.

Shell (SHEL) closed at $102.99, up 1.38%, outperforming the S&P 500. The company is expected to report earnings on October 29, 2026, with predicted EPS of $3.25 (74.73% growth) and revenue of $92.71 billion (31.67% growth). Shell holds a Zacks Rank #1 (Strong Buy) rating with consensus EPS estimates rising 6.18% over the last 30 days.

Rexel has successfully completed a capital increase of approximately €500 million without shareholders' preferential subscription rights to partially finance its acquisition of GCG. As of September 30, 2026, the company had 311,385,744 shares outstanding with 308,448,880 exercisable voting rights.

Rexel has successfully completed a capital increase of approximately €500 million without shareholders' preferential subscription rights to partially finance its acquisition of GCG. As of October 1, 2026, the company has 311,385,744 shares outstanding with 308,448,880 exercisable voting rights.